HOME >> BIOLOGY >> NEWS
A Cup Of Tea May Protect Against Skin Cancer

New findings presented by the CSIRO Division of Human Nutrition at the inaugural Australian International Symposium on Tea and Health in Sydney today, have shown that tea may contribute significant protection against development of skin cancers caused by exposure to ultraviolet (UV) rays.

The latest research with mice found those given tea (with milk) experienced a reduction in the development of skin cancer of 50 per cent and a reduction in the development of papillomas of 70 per cent.

Australia has the highest rate of skin cancer in the world. Currently two out of three Australians develop some form of skin cancer during their lifetime.

Ultraviolet radiation is present in the sun's rays throughout the year. The level of UV varies from day to day, and even on a clear day in September or April it is strong enough to burn your skin.

Tea is a rich source of special antioxidants called flavonoids, considered to be some of the most potent antioxidants in nature. Scientists believe antioxidants in the diet have an important role to play in the fight against diseases including cancer.

The important new CSIRO study examined the effect of providing tea with 10% milk, (compared to just 10% milk or just water) as the sole drinking fluid on UVA+B induced skin cancer in mice. The key finding was a significant reduction in the development of skin cancers in mice drinking tea with milk.

"These findings are significant because initially it was thought milk may bind to the flavonoids, and impact on the antioxidant properties and potential health benefits of tea. The most recent findings would suggest that the flavonoids still play a protective role in the presence of milk," said Dr Ian Record of CSIRO Division of Human Nutrition.

"Intensive research is currently underway into tea flavonoids and how they may help protect the body from potentially harmful substances called fr
'"/>

Contact: DrIan Record
i.record@dhn.csiro.au
61-8-8303-8836
CSIRO Australia
30-Apr-1998


Page: 1 2

Related biology news :

1. Protective gene may enhance vaccine responses
2. Protective mechanism exploited by tumors may provide new cancer treatment
3. Protected wheat varieties
4. Protecting vessel loss in the eyes of premature infants
5. Protecting drinking water from disease transmission by means of zeolite filters
6. Protecting waterbirds from watercraft
7. Protective protein caps discovered at ends of human chromosomes
8. Protecting the rice bowl: Chromosomal mapping of the rice blast fungus
9. Experimental Staph Vaccine Broadly Protective In Animal Studies
10. Enzyme Required To Prolong Life In Worms Identified By Researchers At Columbia; Key Enzyme Appears To Protect Animal Cells From Oxidative Damage
11. Male Moths Sperm Protects Females

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cup Tea May Protect Against Skin Cancer

(Date:7/31/2015)... La 10 th International Conference on Genomics ... 22 al 25 de octubre de 2015 en ... conferencia celebra su décimo aniversario. Desde su inauguración en el ... reuniones anuales más influyentes del mundo en el campo ,ómico, ... y mejores a nivel científico. ICG-10 se ...
(Date:7/31/2015)... -- The 10 th International Conference on Genomics (ICG-10, ... 2015, in Shenzhen , China ... th anniversary this year. Since its inauguration in 2006, ... meetings in the ,omics, fields, and is one of the ... ICG-10 focuses on recent breakthroughs and advances in ,omics, research ...
(Date:7/27/2015)... LOS ANGELES , July 27, 2015 /PRNewswire/ ... providing evidence- and experience-based clinical improvement solutions, today ... coordination solution is now available on Android smartphones ... at inpatient and post-care organizations can use ZynxCarebook ... the same patient,s condition, streamline care transitions to ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/30/2015)... 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... the second $1.0M tranche under a previously awarded ... valued at up to $3.0 million to support ... as a potential medical countermeasure to mitigate acute ... awarded an initial $1.0 million under this grant ...
(Date:7/30/2015)... ... 30, 2015 , ... GEA's Pony™ NS2006L is ... up to 1500 bar. The sanitary design gauge of the NS2006L is well ... The Pony™ NS2006L homogenizer is an ideal solution for the processing of ...
(Date:7/29/2015)... , July 30, 2015 ... santé, publie ses résultats pour le premier semestre ... commente les résultats. Visionner l,interview vidéo ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de l,interview ... - Moteurs de croissance - Diabète ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
Cached News: